Analyst Ratings for Moderna (MRNA)

MRNA Rating Summary

MRNA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MRNA
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $153.29 (-6%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/1/2021 BofA Securities Geoff Meacham Downgrade Underperform
(Neutral)
N/A
(N/A)
173.16
(163.15)
-5.78% Details
12/16/2020 Morgan Stanley
» Updated 5/6/2021
Matthew Harrison Downgrade Equalweight
(Overweight)
201.00
(N/A)
155.07
(163.15)
5.21% Details
Like MRNA Ratings? Also take a look at PFE, AZN, JNJ, BNTX

MRNA Ratings News